Attached files
file | filename |
---|---|
8-K - FORM 8-K - Spansion Inc. | d8k.htm |
Exhibit 99.1
Spansion Inc. Reports Second Quarter 2011 Results
Sunnyvale, California, July 27, 2011 - Spansion Inc. (NYSE: CODE), a leading provider of Flash memory solutions, today announced operating results for its second fiscal quarter ended June 26, 2011. Due to the unique impacts of fresh start accounting, Spansion is providing both GAAP and non-GAAP results. On a U.S. GAAP basis, Spansion reported net sales of $298.8 million, operating income of $36.1 million, and net income of $25.3 million. On a non-GAAP basis, adjusted net sales were $299.1 million, adjusted operating income was $44.9 million, and adjusted net income was $34.1 million.
Spansion executed amid challenging global market conditions, said John Kispert, president and CEO of Spansion. We maintained our NOR market share leadership in the embedded market and we are optimistic about our future as we continue to introduce new products, gain design win momentum and add licensing as a new stream of revenue.
U.S. GAAP results, in $millions except per share data and percentages
Q2 2011 | Q1 2011 | Q2 2010 | ||||||||||
Net sales |
$ | 298.8 | $ | 292.9 | $ | 255.7 | ||||||
Gross margin |
25.9 | % | 23.5 | % | 22.9 | % | ||||||
Operating income (loss) |
$ | 36.1 | $ | (0.7 | ) | $ | (3.0 | ) | ||||
Operating margin |
12.1 | % | (0.0 | %) | (0.0 | %) | ||||||
Net income/(loss) |
$ | 25.3 | ($ | 14.1 | ) | $ | 341.8 | |||||
Diluted net income per share (Predecessor) |
N/A | N/A | $ | 2.21 | ||||||||
Diluted net (loss) per share (Successor) |
$ | 0.40 | $ | (0.23 | ) | $ | (0.31 | ) |
Non-GAAP results, in $millions
Q2 2011 | Q1 2011 | Q2 2010 | ||||||||||
Adjusted net sales |
$ | 299.1 | $ | 294.4 | $ | 292.7 | ||||||
Adjusted operating income |
$ | 44.9 | $ | 38.5 | $ | 40.2 | ||||||
Adjusted net income |
$ | 34.1 | $ | 25.1 | $ | 27.4 | ||||||
Adjusted EBITDA |
$ | 73.7 | $ | 66.6 | $ | 68.4 |
Upon emergence from bankruptcy on May 10, 2010, Spansion adopted fresh start accounting in accordance with U.S. GAAP. The adoption of fresh start accounting resulted in Spansion becoming a new entity for financial reporting purposes, whereby the U.S. GAAP financial statements on or after May 10, 2010 are not comparable to the financial statements prior to that date. Fresh start accounting required resetting the historical net book values of Spansions assets and liabilities to the related fair values. References to Successor refer to Spansion and
1
its consolidated subsidiaries after May 10, 2010, after giving effect to the cancellation of old common stock issued prior to May 10, 2010, the issuance of new common stock and settlement of existing debt and other adjustments in accordance with the reorganization plan, and the application of fresh start accounting. References to Predecessor refer to Spansion and its consolidated subsidiaries prior to May 10, 2010.
Business Outlook
For the third quarter of 2011, Spansion estimates U.S. GAAP net sales in the range of $285 million to $325 million, GAAP net income per diluted share of $0.42 to $0.54.
The following non-cash charges are included in the guidance above
($ in millions) Favorable/(Unfavorable) |
COGS | R&D | SG&A | Operating Income |
Tax | Net Income |
||||||||||||||||||
Fresh Start Inventory Adjustment |
12.6 | | | 12.6 | | 12.6 | ||||||||||||||||||
Intangible Amortization |
6.3 | | | 6.3 | | 6.3 | ||||||||||||||||||
Stock Based Compensation |
1.0 | 1.5 | 3.3 | 5.8 | | 5.8 | ||||||||||||||||||
Total |
19.9 | 1.5 | 3.3 | 24.7 | | 24.7 | ||||||||||||||||||
EPS excluding the above items is expected to be between $0.81 and $0.93
Quarterly Conference Call
Spansion will host a conference call to discuss second quarter 2011 results at 1:30 pm PDT / 4:30 pm EDT today.A live webcast of the conference call, together with a slide presentation that includes supplemental financial information and reconciliations of certain non-GAAP measures to their nearest comparable GAAP measures, can be accessed through the investor relations section of Spansions website at http://investor.spansion.com/
Dial-in: 1-866-788-0542 (US), 1-857-350-1680 (International), Passcode: 98646575
An audio replay will be available within two hours of the call and may be accessed via dial-in at 1-888-286-8010, international 1-617-801-6888 with the Passcode of 36022600 or by webcast on the investor relations section of Spansions website at http://investor.spansion.com/
Use of Non-GAAP Financial Information
The non-GAAP and supplemental information provided in this press release is a supplement to, and not a substitute for or superior to, the companys financial results presented in accordance with U.S. GAAP. The non-GAAP financial measures presented by the company may be different than non-GAAP financial measures presented by other companies.
The non-GAAP and supplemental information is provided to enhance the users overall understanding of the companys operating performance. Specifically, the company believes the non-GAAP information provides useful measures to investors regarding the companys financial performance by excluding certain costs and expenses that the company believes are not
2
indicative of its core operating results. The presentation of non-GAAP and supplemental information is not meant to be considered in isolation or as a substitute for results prepared and presented in accordance with U.S. GAAP. A reconciliation of each non-GAAP financial measure to the most direct, comparable GAAP financial measure is included below.
About Spansion
Spansions (NYSE: CODE) technology is at the heart of electronics systems, powering everything from the internet of today to the smart grid of tomorrow, positively impacting peoples daily lives at work and play. Spansions broad Flash memory product portfolio, smart innovation and industry leading service and support are enabling customers to achieve greater efficiency and success in their target markets.For more information, visit http://www.spansion.com.
Spansion®, the Spansion logo, MirrorBit®, MirrorBit® Eclipse and combinations thereof, are trademarks and registered trademarks of Spansion LLC in the United States and other countries. Other names used are for informational purposes only and may be trademarks of their respective owners.
Cautionary Statement
This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those statements. The risks and uncertainties include the companys ability to: manage costs; achieve adequate liquidity; execute its new strategic focus; reach a sustainable business model; survive as a stand-alone entity; reach operational efficiency; and reach and sustain profitability. Additional risks related to the companys recent emergence from bankruptcy include: any negative impacts on the companys business, results of operations, financial position or cash management arrangements; the negative impact on relationships with employees, customers, suppliers and contract manufacturers and other stakeholders; and the failure of the company to successfully implement the plan of reorganization. In addition, the instability of the global economy and tight credit markets could continue to adversely impact the companys business in several respects, including adversely impacting credit quality and insolvency risk of the company and its customers and business partners, including suppliers and distributors; bookings; and reductions and deferrals of demand for Spansion products. The company urges investors to review in detail the risks and uncertainties discussed in the companys Securities and Exchange Commission filings, including but not limited to the companys most recent Annual Report on Form 10-K for fiscal 2009 and Quarterly Reports on Form 10-Q. Unless otherwise required by applicable laws, the company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Press Contact: | Investor Relations: | |
Michele Landry | Shubham Maheshwari | |
Spansion Inc. | Spansion Inc. | |
+1.408.616.3817 | +1.408.616.3677 | |
michele.landry@spansion.com | shubham.maheshwari@spansion.com | |
Company News: | Investor Relations Web site: | |
http://www.spansion.com/news | http://investor.spansion.com/financials.cfm |
3
Spansion Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share amounts)
Successor | Successor | Successor | Predecessor | |||||||||||||||||||||||||
Three Months Ended June 26, 2011 |
Three Months Ended March 27, 2011 |
Period from May 11, 2010 to June 27, 2010 |
Period
from March 29, 2010 to May 10, 2010 |
|||||||||||||||||||||||||
Net sales |
$ | 298,768 | $ | 292,937 | $ | 124,569 | $ | 101,786 | ||||||||||||||||||||
Net sales to related parties |
| | 4,801 | 24,496 | ||||||||||||||||||||||||
Total net sales |
$ | 298,768 | $ | 292,937 | $ | 129,370 | $ | 126,282 | ||||||||||||||||||||
Cost of sales |
221,336 | 224,165 | 111,413 | 85,697 | ||||||||||||||||||||||||
Gross Profit |
77,432 | 68,772 | 17,957 | 40,585 | ||||||||||||||||||||||||
Research and development |
30,567 | 29,829 | 13,420 | 12,115 | ||||||||||||||||||||||||
Sales, general and administrative |
10,779 | 39,683 | 18,259 | 20,497 | ||||||||||||||||||||||||
Restructuring credits |
| | | (2,785 | ) | |||||||||||||||||||||||
Operating income (loss) before reorganization items |
36,086 | (740 | ) | (13,722 | ) | 10,758 | ||||||||||||||||||||||
Interest & other income (expense), net |
(288 | ) | 747 | 364 | (3,190 | ) | ||||||||||||||||||||||
Interest expense |
(8,779 | ) | (9,058 | ) | (4,877 | ) | (11,237 | ) | ||||||||||||||||||||
Income (loss) before reorganization items and income taxes |
27,019 | (9,051 | ) | (18,235 | ) | (3,669 | ) | |||||||||||||||||||||
Reorganization items |
| | | 364,876 | ||||||||||||||||||||||||
Income (loss) before income taxes |
27,019 | (9,051 | ) | (18,235 | ) | 361,207 | ||||||||||||||||||||||
Provision (benefit) for income taxes |
1,731 | 5,097 | (21 | ) | 1,235 | |||||||||||||||||||||||
Net income (loss) |
$ | 25,288 | $ | (14,148 | ) | $ | (18,214 | ) | $ | 359,972 | ||||||||||||||||||
Net income (loss) per common share |
||||||||||||||||||||||||||||
Basic |
$ | 0.41 | $ | (0.23 | ) | $ | (0.31 | ) | $ | 2.22 | ||||||||||||||||||
Diluted |
$ | 0.40 | $ | (0.23 | ) | $ | (0.31 | ) | $ | 2.21 | ||||||||||||||||||
Shares used in per share calculation |
||||||||||||||||||||||||||||
Basic |
62,106 | 62,140 | 59,271 | 162,513 | ||||||||||||||||||||||||
Diluted |
63,617 | 62,140 | 59,271 | 162,518 | ||||||||||||||||||||||||
4
Spansion Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands)
Successor | ||||||||||||
June 26, 2011 | March 27, 2011 | June 27, 2010 | ||||||||||
Assets |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 292,311 | $ | 283,435 | $ | 254,145 | ||||||
Short term investment |
21,791 | 24,979 | 25,885 | |||||||||
Accounts receivable, net |
130,713 | 158,096 | 139,607 | |||||||||
Accounts receivable from related party |
| | 13,201 | |||||||||
Inventories |
175,140 | 178,428 | 244,536 | |||||||||
Deferred income taxes |
3,897 | 7,258 | 1,141 | |||||||||
Prepaid expenses and other current assets |
49,993 | 57,254 | 44,930 | |||||||||
Total current assets |
673,845 | 709,450 | 723,445 | |||||||||
Property, plant and equipment, net |
224,462 | 245,743 | 329,601 | |||||||||
Intangible assets |
187,095 | 192,722 | 207,276 | |||||||||
Goodwill |
161,974 | 161,936 | 165,553 | |||||||||
Other assets |
48,306 | 36,926 | 41,394 | |||||||||
Total assets |
$ | 1,295,682 | $ | 1,346,777 | $ | 1,467,269 | ||||||
Liabilities and Stockholders Equity (Deficit) |
||||||||||||
Current liabilities: |
||||||||||||
Accounts payable |
95,872 | 97,498 | 30,870 | |||||||||
Accounts payable to related parties |
| | 24,402 | |||||||||
Accrued compensation and benefits |
33,535 | 32,467 | 32,216 | |||||||||
Other accrued liabilities |
52,276 | 97,544 | 218,219 | |||||||||
Income taxes payable |
1,930 | 4,158 | 54 | |||||||||
Deferred income |
26,020 | 27,184 | 8,043 | |||||||||
Current portion of long-term debt and obligations under capital leases |
2,771 | 25,221 | 13,798 | |||||||||
Deferred income taxes |
| | 11,578 | |||||||||
Total current liabilities |
212,404 | 284,072 | 339,180 | |||||||||
Deferred income taxes |
1,304 | 4,728 | 12,073 | |||||||||
Long-term debt, less current portion |
445,538 | 427,549 | 447,733 | |||||||||
Other long-term liabilities |
28,633 | 28,567 | 10,327 | |||||||||
Total liabilities |
687,879 | 744,916 | 809,313 | |||||||||
New Class A Common stock, $0.001 par value, 150,000,000 shares authorized, 61,744,120 shares issued and outstanding |
62 | 63 | 59 | |||||||||
New Class B common stock, $0.001 par value, 1 share authorized, 1 share issued and outstanding |
| | | |||||||||
Additional paid in capital |
694,698 | 714,259 | 675,886 | |||||||||
Retained deficit |
(85,551 | ) | (110,839 | ) | (18,214 | ) | ||||||
Accumulated other comprehensive income |
(1,406 | ) | (1,622 | ) | 225 | |||||||
Total stockholders equity (deficit) |
607,803 | 601,861 | 657,956 | |||||||||
Total liabilities and stockholders equity (deficit) |
$ | 1,295,682 | $ | 1,346,777 | $ | 1,467,269 | ||||||
5
Spansion Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
Successor | Successor | Predecessor | ||||||||||||||||||||||
Three Months Ended June 26, 2011 |
Three Months Ended March 27, 2011 |
Period from May 11, 2010 to June 27, 2010 |
Period from March 29, 2010 to May 10, 2010 |
|||||||||||||||||||||
Cash Flows from Operating Activities: |
||||||||||||||||||||||||
Net income (loss) |
$ | 25,288 | $ | (14,148 | ) | $ | (18,214 | ) | $ | 359,972 | ||||||||||||||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||||||||||||||||||
Depreciation and amortization |
40,931 | 52,083 | 26,146 | 14,482 | ||||||||||||||||||||
Gain on discharge of pre-petition obligations |
| | | (434,046 | ) | |||||||||||||||||||
Provision (benefit) for deferred income taxes |
700 | (1,457 | ) | (3 | ) | 7,000 | ||||||||||||||||||
Impairment on investments in Densbit and Virident |
| | | 3,011 | ||||||||||||||||||||
Net gain on sale and disposal of property, plant and equipment |
(490 | ) | (648 | ) | (266 | ) | (3,219 | ) | ||||||||||||||||
Asset impairment charges |
4,874 | 2,683 | | | ||||||||||||||||||||
Compensation recognized under employee stock plans |
5,048 | 4,548 | 1,945 | 5,757 | ||||||||||||||||||||
Gain on sale of Suzhou plant |
| | (1,342 | ) | (1,548 | ) | ||||||||||||||||||
Amortization of inventory fresh start markup |
1,473 | 6,787 | 18,597 | | ||||||||||||||||||||
Write-off financing cost for old debts |
| | | 13,020 | ||||||||||||||||||||
Changes in assets and liabilities |
(29,936 | ) | (71,236 | ) | (28,293 | ) | 35,443 | |||||||||||||||||
Net cash provided (used) by operating activities |
47,888 | (21,388 | ) | (1,430 | ) | (128 | ) | |||||||||||||||||
Cash Flows from Investing Activities: |
||||||||||||||||||||||||
Proceeds from sale of property, plant and equipment |
2,555 | 2,139 | 4,278 | 4,703 | ||||||||||||||||||||
Purchases of property, plant and equipment |
(15,272 | ) | (13,575 | ) | (4,561 | ) | (5,553 | ) | ||||||||||||||||
Proceeds from redemption of auction rate securities |
| | 16,750 | 35,100 | ||||||||||||||||||||
Purchases of marketable securities |
(21,791 | ) | | | | |||||||||||||||||||
Proceeds from redemption of marketable securities |
24,979 | | | | ||||||||||||||||||||
Decrease in restricted cash |
| | | 531,516 | ||||||||||||||||||||
Purchase of distribution business |
| | (13,125 | ) | | |||||||||||||||||||
Cash proceeds from sale of Suzhou plant |
| | | | ||||||||||||||||||||
Net cash provided (used) by investing activities |
(9,529 | ) | (11,436 | ) | 3,342 | 565,766 | ||||||||||||||||||
Cash Flows from Financing Activities: |
||||||||||||||||||||||||
Proceeds from issuance of common stock due to options exercised |
4,378 | | | | ||||||||||||||||||||
Payments on debt and capital lease obligations |
(4,543 | ) | (1,463 | ) | (2,715 | ) | (661,157 | ) | ||||||||||||||||
Proceeds from rights offering |
| | | 29,092 | ||||||||||||||||||||
Cash settlement on hedging activities |
(260 | ) | (268 | ) | | | ||||||||||||||||||
Purchase of bankruptcy claims |
(28,987 | ) | (12,000 | ) | | | ||||||||||||||||||
Net cash used by financing activities |
(29,412 | ) | (13,731 | ) | (2,715 | ) | (632,065 | ) | ||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
(71 | ) | 696 | 219 | | |||||||||||||||||||
Net increase (decrease) in cash and cash equivalents |
8,876 | (45,859 | ) | (584 | ) | (66,427 | ) | |||||||||||||||||
Cash and cash equivalents at the beginning of period |
283,435 | 329,294 | 254,729 | 321,156 | ||||||||||||||||||||
Cash and cash equivalents at end of period |
$ | 292,311 | $ | 283,435 | $ | 254,145 | $ | 254,729 | ||||||||||||||||
6
Use of Non-GAAP Financial Information
To provide investors and others with additional information regarding Spansions operating results, we have disclosed in this press release certain non-GAAP financial measures, including Adjusted net sales, Adjusted operating income, Adjusted net income, and Adjusted EBITDA. These non-GAAP financial measures are a supplement to, and not a substitute for or superior to, the companys results presented in accordance with U.S. GAAP. The non-GAAP financial measures presented by the company may be different than non-GAAP financial measures presented by other companies.
The non-GAAP financial measures are provided to enhance the users overall understanding of the companys operating performance. Specifically, the company believes the non-GAAP information provides useful measures to investors regarding the companys financial performance by excluding certain costs and expenses that the company believes are not indicative of its core operating results, as well as the impact of fresh start accounting. The presentation of these non-GAAP financial measures are not meant to be considered in isolation or as a substitute for results or guidance prepared and presented in accordance with U.S. GAAP.
Spansion has provided a reconciliation of the non-GAAP financial measures used in this release to the most directly comparable GAAP financial measures:
Adjusted net sales differs from GAAP net sales in that it includes revenue lost from product sell-through that was physically located with the distributors as of the date of emergence from Chapter 11 proceedings.
Adjusted operating income differs from GAAP operating income in that it excludes the impact of non-recurring items, fresh start accounting related adjustments, litigation expenses with Samsung, one-time restructuring charges, and other bankruptcy related charges or credits.
Adjusted net income differs from GAAP net income in that it (i) excludes the impact of non-recurring items, fresh start accounting related adjustments, litigation expenses with Samsung, one-time restructuring and reorganization charges or credits, (ii) includes net sales lost from product sell-through that was physically located with distributors as of the date of emergence from Chapter 11 proceedings and (iii) is adjusted for the associated tax impact of all these changes.
Adjusted EBITDA differs from GAAP net income in that it (i) excludes interest expenses, taxes, depreciation, amortization and stock based compensation charges, (ii) excludes the impact of non-recurring items, fresh start accounting related adjustments, litigation expenses with Samsung, one-time restructuring and reorganization charges or credits and write-off of financing costs completed prior to emergence from bankruptcy and (iii) includes net sales lost from product sell-through that was physically located with distributors as of the date of emergence from Chapter 11 proceedings.
Management believes these non-GAAP financial measures:
Reflect Spansions ongoing business in a manner that allows for meaningful period-to-period comparison and analysis of trends in Spansions business, as they exclude expenses that are not reflective of ongoing operating results;
Provide useful information to investors and others in understanding and evaluating Spansions operating results and future prospects in the same manner as management and in comparing financial results across accounting periods;
Reflect net sales for the company more accurately as inventory at the distributors, when sold-through, would not be recognized as revenue per fresh start accounting. The company intends to collect cash from the distributors and this adjustment is non-cash in nature;
Provide additional view of the performance of the company by adding interest expenses, taxes, depreciation and amortization to the net income. Further adjustments due to fresh start accounting, litigation expenses with Samsung, and stock based compensation charges attempt to exclude items that are either non-cash or non-recurring in nature; and
To enable investors to assess the companys compliance with financial covenants under its debt instruments Spansions term loan has maintenance financial covenants that use EBITDA as part of the measures, e.g. Consolidated Leverage
7
ratio, which is a ratio of Indebtedness to Consolidated EBITDA; and Consolidated Interest Coverage Ratio which is a ratio of Consolidated EBITDA to interest expenses.
Reconciliation of U.S. GAAP to non-GAAP financial measures
Net Sales to Adjusted Net Sales
($ in millions) |
Q2 2011 | Q1 2011 | Q2 2010 | |||||||||
GAAP net sales |
298.8 | 292.9 | 255.7 | |||||||||
Add: Net sales lost due to fresh start accounting |
0.3 | 1.4 | 37.0 | |||||||||
Non-GAAP net sales |
299.1 | 294.4 | 292.7 | |||||||||
Operating Income to Adjusted Operating Income |
||||||||||||
($ in millions) |
Q2 2011 | Q1 2011 | Q2 2010 | |||||||||
GAAP operating income / (loss) |
36.1 | (0.7 | ) | (3.0 | ) | |||||||
Add: fresh start operating expense adjustments |
||||||||||||
Net Sales lost due to fresh start accounting |
0.3 | 1.4 | 37.0 | |||||||||
Depreciation |
11.5 | 23.1 | 12.0 | |||||||||
Amortization from intangibles |
5.7 | 5.2 | 2.3 | |||||||||
Inventory Mark-Up |
13.8 | 6.7 | 18.6 | |||||||||
Deferred COGS |
| (0.2 | ) | (27.7 | ) | |||||||
Gain on the sale of Suzhou plant |
| | (0.8 | ) | ||||||||
(Less)/add: restructuring (credits) / charges |
| | (2.8 | ) | ||||||||
Add: litigation expense related to Samsung |
(26.3 | ) | 3.0 | 4.6 | ||||||||
Add: asset impairment charges |
3.8 | | | |||||||||
Adjusted Operating Income |
44.9 | 38.5 | 40.2 | |||||||||
8
Net Income to Adjusted Net Income
($ in millions) |
Q2 2011 | Q1 2011 | Q2 2010 | |||||||||
GAAP net income / (loss) |
25.3 | (14.1 | ) | 341.8 | ||||||||
Add: fresh start operating expense adjustments |
||||||||||||
Net Sales lost due to fresh start accounting |
0.3 | 1.4 | 37.0 | |||||||||
Depreciation |
11.5 | 23.1 | 12.0 | |||||||||
Amortization from intangibles |
5.7 | 5.2 | 2.3 | |||||||||
Inventory Mark-Up |
13.8 | 6.7 | 18.6 | |||||||||
Deferred COGS |
| (0.2 | ) | (27.7 | ) | |||||||
Gain on the sale of Suzhou plant |
| | (0.8 | ) | ||||||||
(Less)/add: restructuring (credits) / charges |
| | (2.8 | ) | ||||||||
(Less)/add: reorganization (gain) / expense |
| | (364.9 | ) | ||||||||
Add: litigation expense related to Samsung |
(26.3 | ) | 3.0 | 4.6 | ||||||||
Add: asset impairment charges |
3.8 | | | |||||||||
Add: Financing charge write-off to interest |
| | 7.3 | |||||||||
Adjusted net income |
34.1 | 25.1 | 27.4 | |||||||||
Net Income to Adjusted EBITDA
($ in millions) |
Q2 2011 | Q1 2011 | Q2 2010 | |||||||||
GAAP net income / (loss) |
25.3 | (14.1 | ) | 341.8 | ||||||||
Add: interest |
9.1 | 8.3 | 18.9 | |||||||||
(Less)/add: reorganization (gain)/expense |
| | (364.9 | ) | ||||||||
Add: taxes |
1.7 | 5.1 | 1.2 | |||||||||
Add: depreciation and amortization |
40.9 | 51.9 | 26.3 | |||||||||
(Less)/add: restructuring (credits)/charges |
| | (2.8 | ) | ||||||||
Add: fresh start adjustments |
14.2 | 7.9 | 41.4 | |||||||||
Add: asset impairment charges |
3.8 | | | |||||||||
Add: litigation expense related to Samsung |
(26.3 | ) | 3.0 | 4.6 | ||||||||
Add: stock based compensation charges |
5.0 | 4.5 | 1.9 | |||||||||
Adjusted EBITDA |
73.7 | 66.6 | 68.4 | |||||||||
9